Eric Weinberg - Rxsight Chief Officer
| RXST Stock | USD 57.22 1.49 2.54% |
Insider
Eric Weinberg is Chief Officer of Rxsight
| Age | 63 |
| Address | 100 Columbia, Aliso Viejo, CA, United States, 92656 |
| Phone | 949 521 7830 |
| Web | https://www.rxsight.com |
Eric Weinberg Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eric Weinberg against Rxsight stock is an integral part of due diligence when investing in Rxsight. Eric Weinberg insider activity provides valuable insight into whether Rxsight is net buyers or sellers over its current business cycle. Note, Rxsight insiders must abide by specific rules, including filing SEC forms every time they buy or sell Rxsight'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eric Weinberg over three months ago Sale by Eric Weinberg of 10000 shares of Rxsight |
Rxsight Management Efficiency
The company has return on total asset (ROA) of (0.1545) % which means that it has lost $0.1545 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2881) %, meaning that it created substantial loss on money invested by shareholders. Rxsight's management efficiency ratios could be used to measure how well Rxsight manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.25 in 2024. Return On Capital Employed is likely to drop to -0.33 in 2024. Change To Liabilities is likely to gain to about 6.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 15.2 M in 2024.Similar Executives
| Found 3 records | INSIDER Age | ||
| Maria JD | bioAffinity Technologies Warran | 68 | |
| Xavier MS | bioAffinity Technologies Warran | 54 | |
| Danielle Watson | Heart Test Laboratories | 41 | |
Management Performance
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.15 |
Rxsight Leadership Team
Elected by the shareholders, the Rxsight's board of directors comprises two types of representatives: Rxsight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rxsight. The board's role is to monitor Rxsight's management team and ensure that shareholders' interests are well served. Rxsight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rxsight's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Caroline Vaughn, Vice Resources | ||
| Steve Everly, VP Sales | ||
| Rebecca Williston, Vice Finance | ||
| Matt Haller, Chief Officer | ||
| Alex Huang, Investor Relations | ||
| Ilya Goldshleger, Chief Officer | ||
| Eric Weinberg, Chief Officer | ||
| Roy Freeman, Vice Marketing | ||
| Scott Gaines, Senior Process | ||
| Maureen OConnell, Senior Affairs | ||
| Ronald MD, CEO President | ||
| Shelley Thunen, CFO Secretary |
Rxsight Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rxsight a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.44) % | ||||
| Operating Margin | (0.36) % | ||||
| Current Valuation | 2.01 B | ||||
| Shares Outstanding | 39.25 M | ||||
| Shares Owned By Insiders | 5.10 % | ||||
| Shares Owned By Institutions | 83.73 % | ||||
| Number Of Shares Shorted | 1.4 M | ||||
| Price To Earning | 42.55 X |
Pair Trading with Rxsight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rxsight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rxsight will appreciate offsetting losses from the drop in the long position's value.Moving together with Rxsight Stock
Moving against Rxsight Stock
| 0.92 | CVS | CVS Health Corp Aggressive Push | PairCorr |
| 0.79 | INFU | InfuSystems Holdings | PairCorr |
| 0.79 | PGNY | Progyny | PairCorr |
| 0.75 | NYXH | Nyxoah | PairCorr |
| 0.74 | GEHC | GE HealthCare Techno | PairCorr |
The ability to find closely correlated positions to Rxsight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rxsight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rxsight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rxsight to buy it.
The correlation of Rxsight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rxsight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rxsight moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rxsight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.